Scilex Holding Co (SCLX)
0.86
+0.01
(+1.37%)
USD |
NASDAQ |
May 03, 16:00
0.8495
-0.01
(-1.22%)
After-Hours: 20:00
Scilex Revenue (TTM): 46.74M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.74M |
| September 30, 2023 | 45.20M |
| June 30, 2023 | 46.46M |
| Date | Value |
|---|---|
| March 31, 2023 | 41.80M |
| December 31, 2022 | 38.03M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
38.03M
Minimum
Dec 2022
46.74M
Maximum
Dec 2023
43.65M
Average
45.20M
Median
Sep 2023
Revenue (TTM) Benchmarks
| Sorrento Therapeutics Inc | 64.27M |
| Adial Pharmaceuticals Inc | -- |
| Precision BioSciences Inc | 48.73M |
| Humacyte Inc | -- |
| Perspective Therapeutics Inc | 0.00 |